Literature DB >> 6779894

An unusual presentation of opportunistic mucormycosis.

G Helenglass, J A Elliott, N P Lucie.   

Abstract

Entities:  

Mesh：

Year:  1981        PMID： 6779894      PMCID： PMC1503848          DOI： 10.1136/bmj.282.6258.108-a

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN： 0267-0623


× No keyword cloud information.
  4 in total

1.  Leukopenia and therapy in leukemia as factors predisposing to fatal mycoses. Mucormycosis, aspergillosis, and cryptococcosis.

Authors:  R D BAKER
Journal:  Am J Clin Pathol       Date:  1962-04       Impact factor: 2.493

2.  Phycomycosis complicating leukemia and lymphoma.

Authors:  R D Meyer; P Rosen; D Armstrong
Journal:  Ann Intern Med       Date:  1972-12       Impact factor: 25.391

3.  Pulmonary mucormycosis.

Authors:  G Medoff; G S Kobayashi
Journal:  N Engl J Med       Date:  1972-01-13       Impact factor: 91.245

4.  Superior vena cava syndrome caused by invasive aspergillosis.

Authors:  G Gartenberg; K Einstein; J Jagirdar
Journal:  Chest       Date:  1978-12       Impact factor: 9.410
  4 in total
  11 in total

Review 1.  Systemic zygomycosis.

Authors:  E W Benbow; R W Stoddart
Journal:  Postgrad Med J       Date:  1986-11       Impact factor: 2.401

Review 2.  Novel perspectives on mucormycosis: pathophysiology, presentation, and management.

Authors:  Brad Spellberg; John Edwards; Ashraf Ibrahim
Journal:  Clin Microbiol Rev       Date:  2005-07       Impact factor: 26.132

3.  Disseminated zygomycosis associated with erythroleukaemia: confirmation by lectin stains.

Authors:  E W Benbow; I W Delamore; R W Stoddart; H Reid
Journal:  J Clin Pathol       Date:  1985-09       Impact factor: 3.411

4.  Characteristics of pulmonary mucormycosis and the experiences of surgical resection.

Authors:  Weipeng Shao; Jun Zhang; Shanwu Ma; Hongxiang Feng; Zhenrong Zhang; Chaoyang Liang; Deruo Liu
Journal:  J Thorac Dis       Date:  2020-03       Impact factor: 2.895

Review 5.  Mucormycosis and COVID-19 pandemic: Clinical and diagnostic approach.

Authors:  Asim Azhar; Wajihul Hasan Khan; Parvez Anwar Khan; Khaled Alhosaini; Mohammad Owais; Aijaz Ahmad
Journal:  J Infect Public Health       Date:  2022-02-18       Impact factor: 3.718

6.  Covid-associated pulmonary mucormycosis.

Authors:  Arvind Kumar; Mohan V Pulle; Belal B Asaf; Harsh V Puri
Journal:  Lung India       Date:  2022 Mar-Apr

7.  Lichtheimia ramosa: A Fatal Case of Mucormycosis.

Authors:  Cecilia Mouronte-Roibás; Virginia Leiro-Fernández; Maribel Botana-Rial; Cristina Ramos-Hernández; Guillermo Lago-Preciado; Concepción Fiaño-Valverde; Alberto Fernández-Villar
Journal:  Can Respir J       Date:  2016-03-29       Impact factor: 2.409

8.  Pulmonary Mucormycosis: A Case Report of a Rare Infection with Potential Diagnostic Problems.

Authors:  Salwa O Mekki; Amal A Hassan; Afnan Falemban; Nashwa Alkotani; Salem M Alsharif; Ahmed Haron; Basim Felemban; Mohammad S Iqbal; Aisha Tabassum
Journal:  Case Rep Pathol       Date:  2020-01-06

9.  Pulmonary mucormycosis: a case of pulmonary arterial hypertension, Westermark sign, and bronchopleural fistula.

Authors:  Weipeng Shao; Zhenrong Zhang; Hongxiang Feng; Chaoyang Liang; Deruo Liu
Journal:  J Int Med Res       Date:  2020-11       Impact factor: 1.671

10.  Outcomes of early anti-fungal therapy with aggressive surgical resection in pulmonary mucormycosis.

Authors:  Mohan Venkatesh Pulle; Harsh Vardhan Puri; Belal Bin Asaf; Sukhram Bishnoi; Shikha Sharma; Arvind Kumar
Journal:  Lung India       Date:  2021 Jul-Aug
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.